tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jeffrey La Rosa, 7 are a BUY (100%).
Analyst Jeffrey La Rosa, currently employed at LEERINK, carries an average stock price target met ratio of 33.33% that have a potential upside of 4.97% achieved within 83 days.
Jeffrey La Rosa’s has documented 14 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PYXS, Pyxis Oncology at 02-Jul-2026.
Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for ABBV (ABBVIE) at 2/3/2025. The price target of $210 was fulfilled within 220 days with a profit of $28.83 (15.91%) receiving and performance score of 0.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$50.66 (19.16%)
$265
21 days ago
(10-Sep-2026)
6/7 (85.71%)
$60 (23.53%)
115
Buy Since 12-Sep-2025
$303
$38.66 (14.63%)
$298
1 months 11 days ago
(20-Aug-2026)
2/12 (16.67%)
$41.17 (15.72%)
35
Buy Since 09-Dec-2021
$300
$35.66 (13.49%)
$295
1 months 14 days ago
(17-Aug-2026)
14/16 (87.5%)
$49.67 (19.84%)
506
Hold Since 13-Aug-2026
$300
$35.66 (13.49%)
1 months 18 days ago
(13-Aug-2026)
1/2 (50%)
$49.18 (19.61%)
115
Buy Since 23-Jan-2023
$260
$-4.34 (-1.64%)
$235
1 months 21 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
133
Which stock is Jeffrey La Rosa most bullish on?
What Year was the first public recommendation made by Jeffrey La Rosa?
